Imprivata Urges Hospitals to Ditch the Pager
Imprivata® (NYSE: IMPR), the healthcare IT security company, today launched the #DitchPageBoy social media campaign, to shed light on the risks associated with relying on pagers to communicate within a hospital. Through a series of tongue-in-cheek videos featuring Page Boy, an annoying, intrusive, and inefficient sidekick who causes all kinds of problems for his healthcare professionals and their patients, Imprivata pokes fun at the absurdity of using the obsolete pager in 2016.
To watch #DitchPageBoy videos, visit: https://www.imprivata.com/Meet-Page-Boy .
More information about the campaign can be found here: https://www.imprivata.com/Ditch-Page-Boy .
“Doctors and nurses are the last professions in the world to rely on pagers to do their jobs today. With the advent of digital communications more than a decade ago, pagers, like fax machines, should vanish, especially in settings that demand real-time, seamless communication like hospitals,” said Ed Gaudet, General Manager of the Imprivata Cortext Products Group. “The number of hospitals that still rely on pagers is staggering, and frankly, it’s terrifying that your life could be in the hands of 50 year old technology and antiquated workflows."
A recent Ponemon Institute study found that providers waste an average of 35 minutes per shift in workflows such as admissions, transfers, and emergency response coordination, due to inefficient communication caused by pagers. Such wasted time translates into an annual loss of about $1.75 million per U.S. hospital and more than $11 billion, industry-wide. Named the 2015/2016 Category Leader for Secure Messaging by KLAS and endorsed for secure messaging by the American Hospital Association, Imprivata Cortext is the secure communication platform for healthcare that enables providers to quickly and easily communicate using their mobile device, tablet, or desktop to better coordinate care across groups and multiple affiliated sites.
Imprivata® (NYSE: IMPR), the healthcare IT security company, provides healthcare organizations globally with a security and identity platform that delivers authentication management, fast access to patient information, secure communications, and positive patient identification. Imprivata enables care providers to securely and efficiently access, communicate, and transact patient health information to address critical compliance and security challenges while improving productivity and the patient experience. For more information, please visit www.imprivata.com .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ADC-THERAPEUTICS11.12.2017 07:32 | pressemeddelelse
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-301
ADC-THERAPEUTICS11.12.2017 07:02 | pressemeddelelse
ADC Therapeutics Presents Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-402
FL-GA-TELESIS11.12.2017 06:03 | pressemeddelelse
GA Telesis Launches Leveraged Finance Group with the Appointments of David Lloyd and Nolan Heske
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum